Literature DB >> 2988385

Collagenase in the lower respiratory tract of patients with adult respiratory distress syndrome.

P Christner, A Fein, S Goldberg, M Lippmann, W Abrams, G Weinbaum.   

Abstract

Collagenase activity in the bronchoalveolar lavage (BAL) of patients with adult respiratory distress syndrome (ARDS) was measured against Type I collagen (17 patients) and against Type III collagen (13 patients). Serine protease activity was also measured against Type III collagen (13 patients). Type I collagenase activity was detectable in 12 of 17 and Type III collagenase was detectable in 12 of 13 patients with ARDS. The 10 control subjects had no detectable Types I or III collagenase activity. Total and differential white cell counts were analyzed in the lavage fluid. Although the total counts did not differ between patients with ARDS and control subjects, the percentage of neutrophils was increased more than 25-fold and the percentage of macrophages was reduced almost 10-fold in the ARDS patients. Serial collagenase activity was followed in 1 ARDS survivor. In this patient Type III collagenase activity peaked before the Type I collagenase activity or serine protease activity reached their maximums. Both the latter enzyme activities paralleled the total recoverable cells in the BAL.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2988385     DOI: 10.1164/arrd.1985.131.5.690

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  22 in total

Review 1.  Exogenous surfactant treatments for neonatal respiratory distress syndrome and their potential role in the adult respiratory distress syndrome.

Authors:  T A Merritt; M Hallman; R Spragg; G P Heldt; N Gilliard
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

2.  Cellular mechanisms of acute lung injury: implications for future treatment in the adult respiratory distress syndrome.

Authors:  S C Donnelly; C Haslett
Journal:  Thorax       Date:  1992-04       Impact factor: 9.139

3.  Interstitial collagenase (matrix metalloproteinase-1) expresses serpinase activity.

Authors:  P E Desrochers; J J Jeffrey; S J Weiss
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

Review 4.  The American-European Consensus Conference on ARDS, part 2. Ventilatory, pharmacologic, supportive therapy, study design strategies and issues related to recovery and remodeling.

Authors:  A Artigas; G R Bernard; J Carlet; D Dreyfuss; L Gattinoni; L Hudson; M Lamy; J J Marini; M A Matthay; M R Pinsky; R Spragg; P M Suter
Journal:  Intensive Care Med       Date:  1998-04       Impact factor: 17.440

5.  Inflammatory responses in lungs of rats inhaling coalmine dust: enhanced proteolysis of fibronectin by bronchoalveolar leukocytes.

Authors:  G M Brown; K Donaldson
Journal:  Br J Ind Med       Date:  1989-12

Review 6.  Pathogenesis of indirect (secondary) acute lung injury.

Authors:  Mario Perl; Joanne Lomas-Neira; Fabienne Venet; Chun-Shiang Chung; Alfred Ayala
Journal:  Expert Rev Respir Med       Date:  2011-02       Impact factor: 3.772

7.  Degradation of connective tissue components by lung derived leucocytes in vitro: role of proteases and oxidants.

Authors:  G M Brown; K Donaldson
Journal:  Thorax       Date:  1988-02       Impact factor: 9.139

8.  A genome-wide expression analysis in blood identifies pre-elafin as a biomarker in ARDS.

Authors:  Zhaoxi Wang; Douglas Beach; Li Su; Rihong Zhai; David C Christiani
Journal:  Am J Respir Cell Mol Biol       Date:  2008-01-18       Impact factor: 6.914

Review 9.  New perspectives on basic mechanisms in lung disease. 6. Proteinase imbalance: its role in lung disease.

Authors:  T D Tetley
Journal:  Thorax       Date:  1993-05       Impact factor: 9.139

Review 10.  Utilization of transgenic mice in the study of matrix degrading proteinases and their inhibitors.

Authors:  R Khokha; D C Martin; J E Fata
Journal:  Cancer Metastasis Rev       Date:  1995-06       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.